YY/T 1176-2010Cancer antigen CA15-3 quantitative detection reagent (kit)—Chemiluminescent immunoassay (English PDF)
癌抗原CA15-3定量测定试剂(盒)(化学发光免疫分析法)
This is a limited preview
Buy now to download the full PDF (15 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1176-2010 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
December 27, 2010
Implementation date
June 1, 2012
Scope
YY/T 1176-2010 is the English-translated version of 癌抗原CA15-3定量测定试剂(盒)(化学发光免疫分析法).
YY/T 1176-2010 is the Chinese pharmaceutical industry standard for the reagent kit that measures the cancer antigen CA15-3 quantitatively by chemiluminescent immunoassay.
It specifies the classification, the requirements, the test methods, the identification, the labels, the instructions and the rules for packaging, transport and storage, covering the appearance, the traceability of the calibrator, the accuracy, the linear range, the detection limit, the precision, the hook effect and the stability. Issued on 27 December 2010, it applies from 1 June 2012.
Found what you need?
Document preview — YY/T 1176-2010
National Standard of the People's Republic of China
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword3
- 1 Scope4
- 2 Normative references4
- 3 Classification4
- 4 Requirements5
- 5 Test methods6
- 6 Marks, labels and instructions9
- 7 Packaging, transportation and storage11
- Bibliography12
Foreword
This standard was drafted in accordance with the rules specified in GB/T 1.1-2009.
1 Scope
This standard specifies the classification, requirements, test method, identification, labels, instructions, packaging, transportation and storage of the cancer antigen CA15-3 quantitative detection reagent (kit) (chemiluminescent immunoassay).
This standard is applicable to test cancer antigen CA15-3 reagent (kit) [hereinafter referred to as "CA15-3 reagent (kit)"], based on the principles of chemiluminescent immunoassay. It includes the enzymatic and non-enzymatic chemiluminescent immunoassay detection reagent (kit) with carriers of microwell plates, tubes, magnetic particles, micro-beads and plastic-beads. The Standard is not applicable to.
a) The tumor marker calibrators and tumor marker control materials that are intended for separate sales.
b) Biochip that uses the principle of chemiluminescent immunoassay.
2 Normative references
The articles contained in the following documents have become part of this document when they are quoted herein. For the dated documents so quoted, all the modifications (Including all corrections) or revisions made thereafter shall be applicable to this document.
GB/T 21415-2008 In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials
3 Classification
CA15-3 reagent (kit) can be divided into enzymatic and non-enzymatic chemiluminescent immunoassay reagent (kit), according to different chemiluminescent principles. According to different solid-phase carriers, it can be divided into microwell plates, tubes, magnetic particles, micro-beads and plastic-beads as the carrier of chemiluminescent immunoassay reagent (kit). According to different operation processes, it can be divided into manual operation method and instrument-automatic operation method.
4 Requirements
4.1 Appearance
The appearance shall comply with the following requirements.
a) Each component of reagent (kit) shall be complete, intact and no leakage of liquid;
b) The packaging labels shall be clear and easy to be identified.
4.2 Traceability
The manufacturer shall provide the contents such as source, assignment procedure and measurement uncertainty of the applied CA15-3 calibrators in accordance with GB/T21415-2008 and relevant regulations.
4.3 Accuracy
The accuracy shall comply with one of the following requirements.
a) Use the reference materials as the sample for detection. The relative deviation of the measurement results shall be within the range of ± 10%;
b) The recovery rate shall be within the range of (85% to 115%).
Note: If CA15-3 has the international reference materials or national standard products, detect in accordance with Term a); if there are no international reference materials or national standard products, then in accordance with b) for detection.
4.4 Minimum detection limit
The minimum detection limit shall not be greater than 1.0 U/mL.
4.5 Linearity
The upper limit of linear range shall not be less than 5 times the reference value. The lower limit shall not be greater than 1/5 times the reference value. The correlation coefficient r shall not be less than 0.9900 within the linear range prescribed by the manufacturer.
4.6 Repeatability
Use the samples with the concentrations of (30±6) U/mL and (150±30) U/mL to repeatedly and respectively test for 10 times. The coefficient of variation (CV) shall not be greater than 10% (instrument-automatic operation) or not be greater than 15% (manual operation). SD - Standard deviation of 30-times measurement results; M - Mean of 30-times measurement results.
5 Test methods
5.8 Stability
The following methods can be used for verification.
a) Stability within the validity. Take the kit that has been expired to perform the detection in accordance with methods of 5.3-5.6. It shall comply with the requirements in 4.8 a);
b) Thermal stability test. A kit within the validity is placed for 3 days at 37°C. Perform the test according to methods of 5.3-5.6. The result shall comply with requirements of 4.8 b).
6 Marks, labels and instructions
6.1 Marks, labels for outer package of reagent (kit)
a) Product name and packaging specifications;
b) Name, address, contact details of the manufacturer or after-sales service organization;
c) Medical device registration certificate number;
d) Product standard number;
e) Product batch number;
f) Expiration date; g) Storage conditions.
6.2 Marks and labels on each component packing of reagent (kit)
It shall contain at least the following contents.
a) Product name and packaging specifications;
b) Name or trademark of the manufacturer;
c) Product batch number;
d) Expiration date; e) Storage conditions.
7 Packaging, transportation and storage
7.1 Packaging
Reagent (kit) shall be packaged according to the requirements of the manufacturer.
7.2 Transportation
Reagent (kit) shall be transported according to the requirements of the manufacturer.
7.3 Storage
Reagent (kit) shall be stored under the conditions specified by the manufacturer.
Bibliography 1.YY/T 0316-2008 Medical devices - Application of risk management to medical devices (ISO 14971:2007, IDT)
2.YY/T 0466.1-2009 Devices - Symbols to be used with medical device labels, labelling and information to be supplied - Part 1: General requirements (ISO 15223.1-2009, IDT)
4.GB/T 9969-2008 General principles for preparation of instructions for use of industrial products […]
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 15 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1176-2010
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Fast delivery
After payment you'll receive an email confirmation. The English PDF is sent to the same address, usually within minutes and at the latest within 1 business day.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 21415-2008 — In vitro diagnostic medical devices - Measurement of quantities in biological samples - Metrological traceability of values assigned to calibrators and control materials
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
YY/T 0463-2026 — Dentistry - Refractory investment and die materials
YY/T 1176-2010
$125.00